In this regard, recent trials investigated the plasma concentrations of NT-proBNP, troponin T, and IGF-BP2 in patients with CKD and reported a higher prognostic value of the investigated biomarkers in these patients [61,62]. The gene discussed is IGFBP2; the disease is chronic kidney disease.